Valuation: SMAIO

Market Cap 37.51M 42.22M 35.01M 31.91M 60.19M 4.06B 60.75M 424M 164M 2.07B 159M 155M 6.66B P/E 2026 *
-17.1x
P/E 2027 * 167x
Enterprise Value 36.01M 40.53M 33.61M 30.64M 57.78M 3.9B 58.32M 407M 158M 1.99B 152M 149M 6.39B EV / Sales 2026 *
3.27x
EV / Sales 2027 * 2.29x
Free-Float
14.95%
Yield 2026 *
-
Yield 2027 * -
1 day-1.48%
1 week-6.46%
Current month-1.48%
1 month-11.90%
3 months-19.76%
6 months-7.50%
Current year+6.56%
1 week 6.54
Extreme 6.54
7.52
1 month 6.16
Extreme 6.16
7.66
Current year 6
Extreme 6
9.1
1 year 5.9
Extreme 5.9
9.1
3 years 2.25
Extreme 2.25
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 28/12/2008
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2020
Director TitleAgeSince
Chairman - 29/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-6.46%-2.77%+158.14% 42.22M
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average -0.36%-3.70%+24.18%+67.25% 369.72B
Weighted average by Cap. +0.42%-3.33%+30.52%+68.96%

Financials

2026 *2027 *
Net sales 11M 12.38M 10.27M 9.36M 17.65M 1.19B 17.81M 124M 48.14M 608M 46.48M 45.47M 1.95B 16M 18.01M 14.93M 13.61M 25.67M 1.73B 25.91M 181M 70.03M 885M 67.61M 66.14M 2.84B
Net income -2.25M -2.53M -2.1M -1.91M -3.61M -243M -3.64M -25.41M -9.85M -124M -9.51M -9.3M -399M 250K 281K 233K 213K 401K 27.05M 405K 2.82M 1.09M 13.83M 1.06M 1.03M 44.38M
Net Debt -1.5M -1.69M -1.4M -1.28M -2.41M -162M -2.43M -16.94M -6.57M -82.97M -6.34M -6.2M -266M -900K -1.01M -840K -766K -1.44M -97.38M -1.46M -10.17M -3.94M -49.78M -3.8M -3.72M -160M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
02/10/26 €6.660 -1.48% 26
01/10/26 €6.760 0.00% 2
30/09/26 €6.760 -0.59% 1,137
29/09/26 €6.800 -0.29% 776
28/09/26 €6.820 -4.21% 1,177
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.660EUR
Average target price
8.200EUR
Spread / Average Target
+23.12%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock